4//SEC Filing
Randolph Sophia 4
Accession 0001415889-24-013237
CIK 0001810182other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:30 PM ET
Size
7.1 KB
Accession
0001415889-24-013237
Insider Transaction Report
Form 4
Randolph Sophia
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-05-13$15.82/sh−10,203$161,380→ 332,146 total - Sale
Common Stock
2024-05-13$16.67/sh−1,797$29,959→ 330,349 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 11, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.465 to $16.4602, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $16.94, inclusive.
Documents
Issuer
ALX ONCOLOGY HOLDINGS INC
CIK 0001810182
Entity typeother
Related Parties
1- filerCIK 0001817127
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:30 PM ET
- Size
- 7.1 KB